scholarly journals Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis Rehder

In Vivo ◽  
2018 ◽  
Vol 32 (2) ◽  
2014 ◽  
Vol 42 (4) ◽  
pp. 1101-1106 ◽  
Author(s):  
Andrzej Szutowicz ◽  
Hanna Bielarczyk ◽  
Anna Ronowska ◽  
Sylwia Gul-Hinc ◽  
Joanna Klimaszewska-Łata ◽  
...  

Intramitochondrial decarboxylation of glucose-derived pyruvate by PDHC (pyruvate dehydrogenase complex) is a principal source of acetyl-CoA, for mitochondrial energy production and cytoplasmic synthetic pathways in all types of brain cells. The inhibition of PDHC, ACO (aconitase) and KDHC (ketoglutarate dehydrogenase complex) activities by neurodegenerative signals such as aluminium, zinc, amyloid β-peptide, excess nitric oxide (NO) or thiamine pyrophosphate deficits resulted in much deeper losses of viability, acetyl-CoA and ATP in differentiated cholinergic neuronal cells than in non-differentiated cholinergic, and cultured microglial or astroglial cell lines. In addition, in cholinergic cells, such conditions caused inhibition of ACh (acetylcholine) synthesis and its quantal release. Furthermore, cholinergic neuronal cells appeared to be resistant to high concentrations of LPS (lipopolysaccharide). In contrast, in microglial cells, low levels of LPS caused severalfold activation of NO, IL-6 (interleukin 6) and TNFα (tumour necrosis factor α) synthesis/release, accompanied by inhibition of PDHC, KDHC and ACO activities, and suppression of acetyl-CoA, but relatively small losses in their ATP contents and viability parameters. Compounds that protected these enzymes against inhibitory effects of neurotoxins alleviated acetyl-CoA and ATP deficits, thereby maintaining neuronal cell viability. These data indicate that preferential susceptibility of cholinergic neurons to neurodegenerative insults may result from competition for acetyl-CoA between mitochondrial energy-producing and cytoplasmic ACh-synthesizing pathways. Such a hypothesis is supported by the existence of highly significant correlations between mitochondrial/cytoplasmic acetyl-CoA levels and cell viability/transmitter functions respectively.


2013 ◽  
Vol 20 (5) ◽  
pp. 550-561
Author(s):  
Mai Panchal ◽  
Boutaina El Abida ◽  
Noureddine Lazar ◽  
Christine Fahy ◽  
Lionel Dubost ◽  
...  

2010 ◽  
Vol 22 (2) ◽  
pp. 641-652 ◽  
Author(s):  
Gerard Ill-Raga ◽  
Eva Ramos-Fernández ◽  
Francesc X. Guix ◽  
Marta Tajes ◽  
Mónica Bosch-Morató ◽  
...  

2018 ◽  
Vol 475 (19) ◽  
pp. 3087-3103 ◽  
Author(s):  
Ofek Oren ◽  
Victor Banerjee ◽  
Ran Taube ◽  
Niv Papo

Aggregation and accumulation of the 42-residue amyloid β peptide (Aβ42) in the extracellular matrix and within neuronal cells is considered a major cause of neuronal cell cytotoxicity and death in Alzheimer's disease (AD) patients. Therefore, molecules that bind to Aβ42 and prevent its aggregation are therapeutically promising as AD treatment. Here, we show that a non-self-aggregating Aβ42 variant carrying two surface mutations, F19S and L34P (Aβ42DM), inhibits wild-type Aβ42 aggregation and significantly reduces Aβ42-mediated cell cytotoxicity. In addition, Aβ42DM inhibits the uptake and internalization of extracellularly added pre-formed Aβ42 aggregates into cells. This was the case in both neuronal and non-neuronal cells co-expressing Aβ42 and Aβ42DM or following pre-treatment of cells with extracellular soluble forms of the two peptides, even at high Aβ42 to Aβ42DM molar ratios. In cells, Aβ42DM associates with Aβ42, while in vitro, the two soluble recombinant peptides exhibit nano-molar binding affinity. Importantly, Aβ42DM potently suppresses Aβ42 amyloid aggregation in vitro, as demonstrated by thioflavin T fluorescence and transmission electron microscopy for detecting amyloid fibrils. Overall, we present a new approach for inhibiting Aβ42 fibril formation both within and outside cells. Accordingly, Aβ42DM should be evaluated in vivo for potential use as a therapeutic lead for treating AD.


2004 ◽  
Vol 38 (5) ◽  
pp. 449-458 ◽  
Author(s):  
Rukhsana Sultana ◽  
Shelley Newman ◽  
Hafiz Mohmmad-Abdul ◽  
Jeffery N. Keller ◽  
D. Allan Butterfield

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0134486 ◽  
Author(s):  
Hye Rin Lee ◽  
Hwa Kyoung Shin ◽  
So Youn Park ◽  
Hye Young Kim ◽  
Sun Sik Bae ◽  
...  

ChemBioChem ◽  
2012 ◽  
Vol 13 (16) ◽  
pp. 2335-2338 ◽  
Author(s):  
Yong Jiao ◽  
Yi Zhang ◽  
Yibin Wei ◽  
Zhiwei Liu ◽  
Wenting An ◽  
...  

2002 ◽  
Vol 1233 ◽  
pp. 349-353 ◽  
Author(s):  
Keiichi Kadoyama ◽  
Yoshitaka Takahashi ◽  
Haruhiro Higashida ◽  
Tadashi Tanabe ◽  
Tanihiro Yoshimoto

Sign in / Sign up

Export Citation Format

Share Document